Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (122)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Locatelli, F.
Right arrow Articles by Marcelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Locatelli, F.
Right arrow Articles by Marcelli, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Dialysis and Transplantation News

The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry

F Locatelli, F Conte, and D Marcelli

You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
U. P. Udayaraj, Y. Ben-Shlomo, P. Roderick, R. Steenkamp, D. Ansell, C. R.V. Tomson, and F. J. Caskey
Ethnicity, Socioeconomic Status, and Attainment of Clinical Practice Guideline Standards in Dialysis Patients in the United Kingdom
Clin. J. Am. Soc. Nephrol., May 1, 2009; 4(5): 979 - 987.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
A. von Drygalski and J. Biller
Anemia in Cystic Fibrosis: Incidence, Mechanisms, and Association With Pulmonary Function and Vitamin Deficiency
Nutr Clin Pract, October 1, 2008; 23(5): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. D. Kilpatrick, C. W. Critchlow, S. Fishbane, A. Besarab, C. Stehman-Breen, M. Krishnan, and B. D. Bradbury
Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis Patients
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1077 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
S. Tomasello
Anemia of Chronic Kidney Disease
Journal of Pharmacy Practice, June 1, 2008; 21(3): 181 - 195.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Portoles, J. M. Lopez-Gomez, P. Aljama, and on behalf of the MAR Study Group
A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 500 - 507.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Locatelli, L. Del Vecchio, and P. Pozzoni
Anemia and Cardiovascular Risk: The Lesson of the CREATE Trial
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S262 - S266.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. L. Roberts, R. N. Foley, E. D. Weinhandl, D. T. Gilbertson, and A. J. Collins
Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels
Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1652 - 1662.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. L. Regidor, J. D. Kopple, C. P. Kovesdy, R. D. Kilpatrick, C. J. McAllister, J. Aronovitz, S. Greenland, and K. Kalantar-Zadeh
Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1181 - 1191.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
F. K. Port, R. L. Pisoni, J. Bommer, F. Locatelli, M. Jadoul, G. Eknoyan, K. Kurokawa, B. J. Canaud, M. P. Finley, and E. W. Young
Improving Outcomes for Dialysis Patients in the International Dialysis Outcomes and Practice Patterns Study
Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 246 - 255.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. Chesterton, S. H. Lambie, L. J. Hulme, M. Taal, R. J. Fluck, and C. W. McIntyre
Online measurement of haemoglobin concentration
Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1951 - 1955.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. I. Feldman, M. Joffe, B. Robinson, J. Knauss, B. Cizman, W. Guo, E. Franklin-Becker, and G. Faich
Administration of Parenteral Iron and Mortality among Hemodialysis Patients
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1623 - 1632.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Locatelli, R. L. Pisoni, C. Combe, J. Bommer, V. E. Andreucci, L. Piera, R. Greenwood, H. I. Feldman, F. K. Port, and P. J. Held
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
Nephrol. Dial. Transplant., January 1, 2004; 19(1): 121 - 132.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. J. Snyder, R. N. Foley, D. T. Gilbertson, E. F. Vonesh, and A. J. Collins
Hemoglobin Levels and Erythropoietin Doses in Hemodialysis and Peritoneal Dialysis Patients in the United States
J. Am. Soc. Nephrol., January 1, 2004; 15(1): 174 - 179.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Toprak, M. Koc, H. Tezcan, I. C. Ozener, E. Akoglu, and A. Oktay
Inferior vena cava diameter determines left ventricular geometry in continuous ambulatory peritoneal dialysis patients: an echocardiographic study
Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2128 - 2133.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
I. C. Macdougall
CREATE: new strategies for early anaemia management in renal insufficiency
Nephrol. Dial. Transplant., June 1, 2003; 18(suppl_2): ii13 - ii16.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P.-Y. Jungers, C. Robino, G. Choukroun, T. Nguyen-Khoa, Z. A. Massy, and P. Jungers
Incidence of anaemia, and use of epoetin therapy in pre-dialysis patients: a prospective study in 403 patients
Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1621 - 1627.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
J. E Marsh and P. A Andrews
Management of the diabetic patient approaching end-stage renal failure
The British Journal of Diabetes & Vascular Disease, March 1, 2002; 2(2): 121 - 126.
[PDF]


Home page
Nephrol Dial TransplantHome page
F. Locatelli, L. D. Vecchio, and S. Andrulli
The modality of dialysis treatment: does it influence the response to erythropoietin treatment?
Nephrol. Dial. Transplant., October 1, 2001; 16(10): 1971 - 1974.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. Silverberg, D. Wexler, D. Sheps, M. Blum, G. Keren, R. Baruch, D. Schwartz, T. Yachnin, S. Steinbruch, I. Shapira, et al.
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1775 - 1780.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. J. MIDDLETON, P. S. PARFREY, and R. N. FOLEY
Left Ventricular Hypertrophy in the Renal Patient
J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1079 - 1084.
[Full Text]


Home page
Nephrol Dial TransplantHome page
F. Locatelli, S. Andrulli, F. Pecchini, L. Pedrini, S. Agliata, L. Lucchi, M. Farina, V. La Milia, C. Grassi, M. Borghi, et al.
Effect of high-flux dialysis on the anaemia of haemodialysis patients
Nephrol. Dial. Transplant., September 1, 2000; 15(9): 1399 - 1409.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. Silverberg, D. Wexler, M. Blum, G. Keren, D. Sheps, E. Leibovitch, D. Brosh, S. Laniado, D. Schwartz, T. Yachnin, et al.
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1737 - 1744.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. J. Will and J. S. Cameron
European guidelines for renal anaemia--predicting 85% compliance
Nephrol. Dial. Transplant., March 1, 2000; 15(3): 439 - 440.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. MORENO, D. SANZ-GUAJARDO, J. M. LOPEZ-GOMEZ, R. JOFRE, and F. VALDERRABANO
Increasing the Hematocrit Has a Beneficial Effect on Quality of Life and Is Safe in Selected Hemodialysis Patients
J. Am. Soc. Nephrol., February 1, 2000; 11(2): 335 - 342.
[Abstract] [Full Text] [PDF]


This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (122)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Locatelli, F.
Right arrow Articles by Marcelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Locatelli, F.
Right arrow Articles by Marcelli, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?